The diagnosis and clinical management of the neuropsychiatric manifestations of lupus

M Govoni, A Bortoluzzi, M Padovan, E Silvagni… - Journal of …, 2016 - Elsevier
Neuropsychiatric (NP) involvement in Systemic Lupus Erythematosus (SLE), can be a
severe and troubling manifestation of the disease that heavily impacts patient's health …

The gut microbiome and multiple sclerosis

J Ochoa-Repáraz, TO Kirby… - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
The microbiome can be defined as the sum of the microbial and host's genome. Recent
information regarding this complex organ suggests that in animal models of multiple …

Serious safety events in rituximab‐treated multiple sclerosis and related disorders

BL Vollmer, AI Wallach, JR Corboy… - Annals of Clinical …, 2020 - Wiley Online Library
Introduction Studies investigating rates and risk factors for serious safety events (SSEs)
during rituximab treatment of multiple sclerosis (MS), neuromyelitis optica spectrum …

B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro

RP Lisak, L Nedelkoska, JA Benjamins… - Journal of …, 2017 - Elsevier
B cells mediate multiple sclerosis (MS) pathogenesis by mechanisms unrelated to
immunoglobulin (Ig). We reported that supernatants (Sup) from cultured B cells from blood of …

[HTML][HTML] The role of the gut microbiome in multiple sclerosis risk and progression: towards characterization of the “MS microbiome”

AK Pröbstel, SE Baranzini - Neurotherapeutics, 2018 - Elsevier
Multiple sclerosis (MS) is the prototypic complex disease, in which both genes and the
environment contribute to its pathogenesis. To date,> 200 independent loci across the …

B cells in multiple sclerosis

H Wekerle - Autoimmunity, 2017 - Taylor & Francis
B lymphocytes have essential roles in the autoimmune pathogenesis of multiple sclerosis
(MS). They regulate the autoimmune response and participate in the development of the …

[HTML][HTML] Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis

W Gilmore, BT Lund, P Li, AM Levy, EE Kelland… - Journal of …, 2020 - Springer
Objective To characterize long-term repopulation of peripheral immune cells following
alemtuzumab-induced lymphopenia in relapsing-remitting MS (RRMS), with a focus on …

B-cell therapies in multiple sclerosis

JJ Sabatino, SS Zamvil… - Cold Spring …, 2019 - perspectivesinmedicine.cshlp.org
B cells play a vital function in multiple sclerosis (MS) pathogenesis through an array of
effector functions. All currently approved MS disease–modifying therapies alter the …

[HTML][HTML] The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle

NS Elsayed, P Aston, VR Bayanagari… - Frontiers in …, 2022 - frontiersin.org
The etiological complexity of multiple sclerosis, an immune-mediated, neurodegenerative
disease with multifactorial etiology is still elusive because of an incomplete understanding of …

Potential therapeutic applications of exosomes in different autoimmune diseases

H Xu, S Jia, H Xu - Clinical Immunology, 2019 - Elsevier
Autoimmune diseases are caused by self-immune responses to autoantigens, which
damage body tissues and severely affect the patient's quality of life. Therapeutic drugs are …